Current and historical daily PE Ratio for PharmaResearch Co Ltd (
) from 2015 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. PharmaResearch stock (XKRX:214450) PE ratio as of Jun 05 2024 is 17.62.
More Details
PharmaResearch Co Ltd (XKRX:214450) PE Ratio (TTM) Chart
PharmaResearch Co Ltd (XKRX:214450) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1267
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| PharmaResearch PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | 17.6 | 2024-03-28 | 13.4 |
| 2024-06-04 | 17.6 | 2024-03-27 | 13.3 |
| 2024-06-03 | 17.7 | 2024-03-26 | 13.1 |
| 2024-05-31 | 19.8 | 2024-03-25 | 13.2 |
| 2024-05-30 | 19.1 | 2024-03-22 | 12.2 |
| 2024-05-29 | 18.2 | 2024-03-21 | 12.2 |
| 2024-05-28 | 18.0 | 2024-03-20 | 12.3 |
| 2024-05-27 | 18.4 | 2024-03-19 | 12.5 |
| 2024-05-24 | 18.7 | 2024-03-18 | 12.4 |
| 2024-05-23 | 18.3 | 2024-03-15 | 12.2 |
| 2024-05-22 | 17.9 | 2024-03-14 | 12.5 |
| 2024-05-21 | 18.4 | 2024-03-13 | 12.4 |
| 2024-05-20 | 18.7 | 2024-03-12 | 12.1 |
| 2024-05-17 | 18.6 | 2024-03-11 | 11.9 |
| 2024-05-16 | 18.6 | 2024-03-08 | 11.9 |
| 2024-05-14 | 19.8 | 2024-03-07 | 12.0 |
| 2024-05-13 | 19.0 | 2024-03-06 | 12.3 |
| 2024-05-10 | 19.3 | 2024-03-05 | 12.3 |
| 2024-05-09 | 19.0 | 2024-03-04 | 12.4 |
| 2024-05-08 | 18.4 | 2024-02-29 | 12.6 |
| 2024-05-07 | 18.2 | 2024-02-28 | 12.7 |
| 2024-05-03 | 18.9 | 2024-02-27 | 12.3 |
| 2024-05-02 | 17.4 | 2024-02-26 | 12.8 |
| 2024-04-30 | 17.3 | 2024-02-23 | 12.7 |
| 2024-04-29 | 17.4 | 2024-02-22 | 12.3 |
| 2024-04-26 | 16.1 | 2024-02-21 | 12.7 |
| 2024-04-25 | 15.3 | 2024-02-20 | 12.2 |
| 2024-04-24 | 15.6 | 2024-02-19 | 12.3 |
| 2024-04-23 | 15.9 | 2024-02-16 | 12.9 |
| 2024-04-22 | 16.9 | 2024-02-15 | 12.8 |
| 2024-04-19 | 17.5 | 2024-02-14 | 12.8 |
| 2024-04-18 | 17.1 | 2024-02-13 | 13.0 |
| 2024-04-17 | 17.3 | 2024-02-08 | 13.8 |
| 2024-04-16 | 16.8 | 2024-02-07 | 13.4 |
| 2024-04-15 | 17.0 | 2024-02-06 | 13.5 |
| 2024-04-12 | 17.2 | 2024-02-05 | 13.1 |
| 2024-04-11 | 16.7 | 2024-02-02 | 13.5 |
| 2024-04-09 | 16.0 | 2024-02-01 | 13.9 |
| 2024-04-08 | 15.0 | 2024-01-31 | 14.1 |
| 2024-04-05 | 15.4 | 2024-01-30 | 14.5 |
| 2024-04-04 | 14.9 | 2024-01-29 | 14.4 |
| 2024-04-03 | 14.7 | 2024-01-26 | 15.0 |
| 2024-04-02 | 14.0 | 2024-01-25 | 15.1 |
| 2024-04-01 | 14.6 | 2024-01-24 | 15.1 |
| 2024-03-29 | 13.6 | 2024-01-23 | 15.2 |
PharmaResearch Co Ltd (XKRX:214450) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
PharmaResearch Co Ltd
ISIN : KR7214450009
Compare
Compare
Traded in other countries / regions
214450.Korea IPO Date
2015-07-24Description
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers